Results 171 to 180 of about 827 (180)

The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus Acinetobacter baumannii-calcoaceticus Complex

Clinical Infectious Diseases, 2023
John O'Donnell
exaly  

In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii- calcoaceticus Complex Isolates Collected Globally in 2016 and 2017

Antimicrobial Agents and Chemotherapy, 2020
Sarah M McLeod, Samir H Moussa, Meredith A Hackel   +2 more
exaly  

Pharmacokinetics and Tolerability of Intravenous Sulbactam-Durlobactam with Imipenem-Cilastatin in Hospitalized Adults with Complicated Urinary Tract Infections, Including Acute Pyelonephritis

Antimicrobial Agents and Chemotherapy, 2020
K Yanev, Roman Fomkin, John O'Donnell
exaly  

Sulbactam/Durlobactam

Clinical Therapeutics
openaire   +2 more sources

Beyond resistance: assessing sulbactam-durlobactam’s role in today’s clinical landscape

Expert Review of Anti-infective Therapy
openaire   +2 more sources

Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii

Future Microbiology
Sarah M McLeod, John O'Donnell, Navaneeth Narayanan   +2 more
exaly  

Sulbactam-Durlobactam in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

Annals of Pharmacotherapy
Andrew Matlob, Pramodini B Kale-Pradhan
exaly  

Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK)

Antimicrobial Agents and Chemotherapy
Alita A Miller, Samir H Moussa, Sarah M McLeod   +2 more
exaly  

Genomic characterization of Carbapenem-Resistant Acinetobacter baumannii clinical strains resistant to Sulbactam/Durlobactam from Italy

European Journal of Clinical Microbiology & Infectious Diseases
Luca, Caiazzo, Gabriele, Bianco, Matteo, Boattini, Cristina, Costa, Paolo, Gaibani   +4 more
openaire   +2 more sources

Unraveling sulbactam-durlobactam: insights into its role in combating infections caused by Acinetobacter baumannii

Expert Review of Anti-Infective Therapy
Tomefa E Asempa, Joseph L Kuti
exaly